Summit Securities Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Summit Securities Group's PFE Position: Q3 2026 in Review
Summit Securities Group increased its Pfizer (PFE) stake by 36% in Q3 2026, buying an estimated $242K and bringing the position to 34,200 shares worth $975K. The position accounts for 0.09% of the portfolio, ranked #121.
Summit Securities Group first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $15.6M in Q4 2021. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Summit Securities Group held 34,200 shares of Pfizer worth $975K as of Q3 2026.
- Summit Securities Group bought 9,114 Pfizer shares in Q3 2026, an estimated $242K.
- Pfizer made up 0.09% of Summit Securities Group's portfolio in Q3 2026, its #121 holding.
- Summit Securities Group first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Summit Securities Group's Pfizer position peaked at $15.6M in Q4 2021.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.